Novo Nordisk (NYSE:NVO) may not have generated headlines with a specific event this week, but recent share price shifts could have investors taking a closer look. When a stock moves in the absence of ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

GLP-1 receptor agonists have shown strong scientific evidence in helping patients with type 2 diabetes achieve better blood ...

The WHO has added GLP-1 drugs like Ozempic and Mounjaro to its Essential Medicines List, aiming to improve diabetes care access globally while pushing for affordability and wider availability., Health ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

WHO recommends affordable weight-loss drugs for diabetes and obesity, urging generic competition to lower prices globally.

HONOLULU -- Hurricane Kiko was tracking to the north of the Hawaiian islands, diminishing the threat of strong winds and widespread rain, the National Weather Service said Saturday.